Back to Search
MAREN JEFFERY, MD
MD
Cardiovascular Disease Physician
NPI: 1861553406IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
MD422122(PA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 2000
Research & Publications (18)
Failure of an uncemented non-porous metal-backed prosthesis with augmentation using impacted allograft for acetabular revision 12- to 17-year results.
PMID 12678349·J Bone Joint Surg Br·2003
8-other
Transient retinal effects of 5,6-dimethylxanthenone-4-acetic acid (DMXAA, ASA404), an antitumor vascular-disrupting agent in phase I clinical trials.
PMID 19387077·Invest Ophthalmol Vis Sci·2009
3-trial
Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand.
PMID 19143877·Intern Med J·2008
3-trial
Survey of cattle management practices within the Kimberley cattle industry to assist emergency infectious disease preparedness.
PMID 18782417·Aust Vet J·2008
7-preclinical
Fraction size in radiation treatment for breast conservation in early breast cancer.
PMID 18646095·Cochrane Database Syst Rev·2008
1-meta
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
PMID 17947725·J Clin Oncol·2007
2-rct
Minimally invasive resection of papillary fibroelastoma in a high-risk patient.
PMID 17667039·J Cardiovasc Med (Hagerstown)·2007
5-case
Follow-up strategies for patients treated for non-metastatic colorectal cancer.
PMID 17253476·Cochrane Database Syst Rev·2007
1-meta
Enantioselective synthesis and selective monofunctionalization of (4R,6R)-4,6- dihydroxy-2,8-dioxabicyclo[3.3.0]octane.
PMID 17134281·Org Lett·2006
8-other
5,6-Dimethylxanthenone-4-acetic acid in the treatment of refractory tumors: a phase I safety study of a vascular disrupting agent.
PMID 16551862·Clin Cancer Res·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 250 KING OF PRUSSIA RD
RADNOR, PA 19087 - Phone
- (610) 902-2273
Quick Facts
- NPI
- 1861553406
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 18
Are you this provider?
Claim Your Profile